N-[叔丁氧羰基]-N-甲基-D-异亮氨酸 | 267223-87-0

• 物质功能分类: 生物化工 - 生化试剂 - 氨基酸
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: N-[叔丁氧羰基]-N-甲基-D-异亮氨酸
• 中文别名: BOC-D-ME异亮氨酸-OH
• 英文名称: Boc-N-me-DIle-OH
• 英文别名: Boc-D-MeIle-OH；(2R,3R)-3-methyl-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]pentanoic acid
• CAS: 267223-87-0
• 化学式: C₁₂H₂₃NO₄
• 分子量: 245.319
• InChiKey: HTBIAUMDQYXOFG-RKDXNWHRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  17
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  66.8
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• WGK Germany：
  3

反应信息

• 作为反应物：
  描述：

  N-[叔丁氧羰基]-N-甲基-D-异亮氨酸 在 盐酸 作用下， 以 水 为溶剂， 生成 N-甲基-D-异亮氨酸
  参考文献：
  名称：

  Trichormamides A and B with Antiproliferative Activity from the Cultured Freshwater CyanobacteriumTrichormussp. UIC 10339

  摘要：

  Two new cyclic lipopeptides, trichormamides A (1) and B (2), were isolated from the cultured freshwater cyanobacterium Trichormus sp. UIC 10339. The strain was obtained from a sample collected in Raven Lake in Northern Wisconsin. The planar structures of trichormamides A (1) and B (2) were determined using a combination of spectroscopic analyses including HRESIMS and 1D and 2D NMR experiments. The absolute configurations of the amino acid residues were assigned by the advanced Marfey's method after acid hydrolysis. Trichormamide A (1) is a cyclic undecapeptide containing two D-amino acid residues (D-Tyr and D-Leu) and one beta-amino acid residue (beta-aminodecanoic acid). Trichormamide B (2) is a cyclic dodecapeptide characterized by the presence of four nonstandard alpha-amino acid residues (homoserine, N-methylisoleucine, and two 3-hydroxyleucines) and one beta-amino acid residue (beta-aminodecanoic acid). Trichormamide B (2) was cytotoxic against MDA-MB-435 and HT-29 cancer cell lines with IC50 values of 0.8 and 1.5 mu M, respectively.

  DOI：

  10.1021/np5003548
• 作为产物：
  描述：

  Boc-D-异亮氨酸 、 碘甲烷 在 sodium hydride 作用下， 以 四氢呋喃 为溶剂， 反应 26.0h， 生成 N-[叔丁氧羰基]-N-甲基-D-异亮氨酸
  参考文献：
  名称：

  Trichormamides A and B with Antiproliferative Activity from the Cultured Freshwater CyanobacteriumTrichormussp. UIC 10339

  摘要：

  Two new cyclic lipopeptides, trichormamides A (1) and B (2), were isolated from the cultured freshwater cyanobacterium Trichormus sp. UIC 10339. The strain was obtained from a sample collected in Raven Lake in Northern Wisconsin. The planar structures of trichormamides A (1) and B (2) were determined using a combination of spectroscopic analyses including HRESIMS and 1D and 2D NMR experiments. The absolute configurations of the amino acid residues were assigned by the advanced Marfey's method after acid hydrolysis. Trichormamide A (1) is a cyclic undecapeptide containing two D-amino acid residues (D-Tyr and D-Leu) and one beta-amino acid residue (beta-aminodecanoic acid). Trichormamide B (2) is a cyclic dodecapeptide characterized by the presence of four nonstandard alpha-amino acid residues (homoserine, N-methylisoleucine, and two 3-hydroxyleucines) and one beta-amino acid residue (beta-aminodecanoic acid). Trichormamide B (2) was cytotoxic against MDA-MB-435 and HT-29 cancer cell lines with IC50 values of 0.8 and 1.5 mu M, respectively.

  DOI：

  10.1021/np5003548

文献信息

• [EN] AMINOPYRIDINE DERIVATIVES<br/>[FR] DÉRIVÉS D'AMINOPYRIDINE
  申请人：VANTIA LTD

  公开号：WO2009133348A1

  公开（公告）日：2009-11-05

  The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (such as asthma or COPD); and methods of treating patients with such compounds; wherein R1 - R11 are as defined herein.

  本发明提供了式（I）的化合物：包含这些化合物的组合物；在治疗中使用这些化合物（例如哮喘或COPD）；以及使用这些化合物治疗患者的方法；其中R1 - R11如本文所定义。
• [EN] INHIBITORS OF JNK<br/>[FR] INHIBITEURS DE LA JNK
  申请人：HOFFMANN LA ROCHE

  公开号：WO2009138340A1

  公开（公告）日：2009-11-19

  The invention relates to prodrugs of JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses prodrugs of JNK inhibitors, as described below in formula (I), wherein m, n, p, q, Q, r, R1, R2, R3, X, X1, X2, X3, X4, X5, Y1, Y2, Z1, and Z2 are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity. Disclosed are methods and formulations for inhibiting JNK and treating JNK-mediated disorders, and the like, with the compounds, and processes for making said compounds, and corresponding compositions, disclosed herein.

  该发明涉及JNK抑制剂的前药及相应的用于抑制JNK和治疗JNK介导的疾病的方法、配方和组合物。该申请公开了JNK抑制剂的前药，如下所示的化学式(I)，其中m、n、p、q、Q、r、R1、R2、R3、X、X1、X2、X3、X4、X5、Y1、Y2、Z1和Z2如本文所定义。本文披露的化合物和组合物对调节JNK活性和治疗与JNK活性相关的疾病是有用的。公开了用于抑制JNK和治疗JNK介导的疾病等的方法和配方，以及使用这些化合物制备所述化合物的过程和相应的组合物。
• Aminopyridine Derivatives
  申请人：Evans David Michael

  公开号：US20100076015A1

  公开（公告）日：2010-03-25

  The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (such as asthma or COPD); and methods of treating patients with such compounds; wherein R 1 -R 11 are as defined herein.

  本发明提供了式(I)的化合物：包括这些化合物的组合物；在治疗（如哮喘或COPD）中使用这些化合物；以及使用这些化合物治疗患者的方法；其中R1-R11如本文所定义。
• INHIBITORS OF JNK
  申请人：F. Hoffmann-La Roche AG

  公开号：EP2283009A1

  公开（公告）日：2011-02-16
• Trichormamides A and B with Antiproliferative Activity from the Cultured Freshwater Cyanobacterium<i>Trichormus</i>sp. UIC 10339
  作者：Shangwen Luo、Aleksej Krunic、Hahk-Soo Kang、Wei-Lun Chen、John L. Woodard、James R. Fuchs、Steven M. Swanson、Jimmy Orjala

  DOI：10.1021/np5003548

  日期：2014.8.22

  Two new cyclic lipopeptides, trichormamides A (1) and B (2), were isolated from the cultured freshwater cyanobacterium Trichormus sp. UIC 10339. The strain was obtained from a sample collected in Raven Lake in Northern Wisconsin. The planar structures of trichormamides A (1) and B (2) were determined using a combination of spectroscopic analyses including HRESIMS and 1D and 2D NMR experiments. The absolute configurations of the amino acid residues were assigned by the advanced Marfey's method after acid hydrolysis. Trichormamide A (1) is a cyclic undecapeptide containing two D-amino acid residues (D-Tyr and D-Leu) and one beta-amino acid residue (beta-aminodecanoic acid). Trichormamide B (2) is a cyclic dodecapeptide characterized by the presence of four nonstandard alpha-amino acid residues (homoserine, N-methylisoleucine, and two 3-hydroxyleucines) and one beta-amino acid residue (beta-aminodecanoic acid). Trichormamide B (2) was cytotoxic against MDA-MB-435 and HT-29 cancer cell lines with IC50 values of 0.8 and 1.5 mu M, respectively.